Amgen (AMGN) EVP granted RSUs, 17,022 options; 408 shares for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Amgen Inc. executive vice president and general counsel Jonathan P. Graham reported routine equity compensation changes. On May 5, 2026, he received 2,609 shares of common stock at no cost as a grant, increasing his direct holdings to 40,619 shares. The same day, he was granted 17,022 non-qualified stock options with an exercise price of $329.59 per share, exercisable in four equal annual installments starting May 5, 2027 and expiring in 2036. These options relate to an equal number of underlying common shares. On May 6, 2026, 408 shares were disposed of at $329.59 per share to satisfy tax obligations, leaving him with 40,211 shares held directly. The restricted stock units and options vest in four annual installments of 25% each beginning in 2027, and vested RSUs and related dividend equivalents will be settled in common shares on a one-to-one basis.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Graham Jonathan P
Role
EVP & Gen. Counsel & Sec.
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 408 | $329.59 | $134K |
| Grant/Award | Nqso (Right to Buy) | 17,022 | $329.59 | $5.61M |
| Grant/Award | Common Stock | 2,609 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 40,211 shares (Direct, null);
Nqso (Right to Buy) — 17,022 shares (Direct, null)
Footnotes (1)
- The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 370 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
Key Figures
RSU grant: 2,609 shares
Option grant size: 17,022 options
Option exercise price: $329.59 per share
+4 more
7 metrics
RSU grant
2,609 shares
Common stock grant on May 5, 2026
Option grant size
17,022 options
Non-qualified stock options on May 5, 2026
Option exercise price
$329.59 per share
Exercise price for non-qualified stock options
Shares withheld for taxes
408 shares
Tax-withholding disposition on May 6, 2026
Shares after transactions
40,211 shares
Direct common stock holdings following tax withholding
RSU vesting start
May 5, 2027
First 25% installment for RSUs
Option expiration
May 5, 2036
Expiration date of non-qualified stock options
Key Terms
Restricted Stock Units (RSUs), Dividend Equivalents (DEs), non-qualified stock options, Equity Incentive Plan, +1 more
5 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Dividend Equivalents (DEs) financial
"These shares include 370 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan"
non-qualified stock options financial
"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan)"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
FAQ
What insider transactions did Amgen (AMGN) report for Jonathan P. Graham?
Amgen reported that Jonathan P. Graham received 2,609 shares of common stock as a grant and 17,022 non-qualified stock options at $329.59 per share. He also had 408 shares withheld to cover tax obligations related to the equity awards.
What are the key terms of Jonathan P. Graham’s new Amgen stock options?
Graham received 17,022 non-qualified stock options with a $329.59 exercise price. They vest and become exercisable in four equal annual installments of 25% each, beginning on May 5, 2027, and will expire on May 5, 2036 if not exercised.
How do Jonathan P. Graham’s Amgen restricted stock units (RSUs) vest and settle?
His RSUs vest in four equal annual installments of 25% starting May 5, 2027. Once vested, each RSU is paid out in one share of Amgen common stock, along with any credited dividend equivalents, plus cash for any remaining fractional share amount.
Under which plan were Jonathan P. Graham’s Amgen equity awards granted?
Both the restricted stock units and the non-qualified stock options were granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan, which governs vesting schedules, dividend equivalents, and how vested awards are settled in common stock.